Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery
Photoactivatable ligand proteins are potentially useful for light-induced intracellular delivery of therapeutic and diagnostic cargos through receptor-mediated cellular uptake. Here, we report the simple and effective caging of transferrin (Tf), a representative ligand protein with cellular uptake a...
Gespeichert in:
Veröffentlicht in: | Bioconjugate chemistry 2021-08, Vol.32 (8), p.1535-1540 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1540 |
---|---|
container_issue | 8 |
container_start_page | 1535 |
container_title | Bioconjugate chemistry |
container_volume | 32 |
creator | Yamaguchi, Satoshi Takamori, Satoshi Yamamoto, Kazuho Ishiwatari, Akira Minamihata, Kosuke Yamada, Eriko Okamoto, Akimitsu Nagamune, Teruyuki |
description | Photoactivatable ligand proteins are potentially useful for light-induced intracellular delivery of therapeutic and diagnostic cargos through receptor-mediated cellular uptake. Here, we report the simple and effective caging of transferrin (Tf), a representative ligand protein with cellular uptake ability, which has been used in the delivery of various cargos. Tf was modified with several biotin molecules through a photocleavable linker, and then the biotinylated Tf (bTf) was conjugated with the biotin-binding protein, streptavidin (SA), to provide steric hindrance to block the interaction with the Tf receptor. Without exposure to light, the cellular uptake of the bTf-SA complex was effectively inhibited. In response to light exposure, the complex was degraded with the release of Tf, leading to cellular uptake of Tf. Similarly, the cellular uptake of Tf-doxorubicin (Dox) conjugates could be suppressed by caging with biotinylation and SA binding, and the intracellular delivery of Dox could be triggered in a light-dependent manner. The intracellularly accumulated Dox decreased the cell viability to 25% because of the cell growth inhibitory effect of Dox. These results provided proof of principle that the caged Tf can be employed as a photoactivatable molecular device for the intracellular delivery of cargos. |
doi_str_mv | 10.1021/acs.bioconjchem.1c00159 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2557223864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557223864</sourcerecordid><originalsourceid>FETCH-LOGICAL-a451t-abead40f614bf36cfa2b7f978c36b441c896aaa779aea404dee9b54a1d1b29153</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EgvL4BYjEhk2Kx3ZeSyivSkggKOto7NolxY2LnVTK35OqBSE2rGYW594ZHULOgA6BMrhEFYaycsrVc_WuF0NQlEJS7JABJIzGIge22-9U8Bhyyg7IYQhzSmkBOdsnB1xwlnPGBuTltdG-UmhtF1239qOLRjir6lnkTDTxWAejva_qyDgfPb-7xqFqqhU2KK2OxnXjUWlrW4s-utG2WmnfHZM9gzbok-08Im93t5PRQ_z4dD8eXT3GKBJoYpQap4KaFIQ0PFUGmcxMkeWKp1IIUHmRImKWFahRUDHVupCJQJiCZAUk_IhcbHqX3n22OjTlogrrb7DWrg0lS5KMMZ6nokfP_6Bz1_q6_66nMgCeQsp6KttQyrsQvDbl0lcL9F0JtFxrL3vt5S_t5VZ7nzzd9rdyoac_uW_PPcA3wLrh5_Z_tV-wuJUl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2571136162</pqid></control><display><type>article</type><title>Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Yamaguchi, Satoshi ; Takamori, Satoshi ; Yamamoto, Kazuho ; Ishiwatari, Akira ; Minamihata, Kosuke ; Yamada, Eriko ; Okamoto, Akimitsu ; Nagamune, Teruyuki</creator><creatorcontrib>Yamaguchi, Satoshi ; Takamori, Satoshi ; Yamamoto, Kazuho ; Ishiwatari, Akira ; Minamihata, Kosuke ; Yamada, Eriko ; Okamoto, Akimitsu ; Nagamune, Teruyuki</creatorcontrib><description>Photoactivatable ligand proteins are potentially useful for light-induced intracellular delivery of therapeutic and diagnostic cargos through receptor-mediated cellular uptake. Here, we report the simple and effective caging of transferrin (Tf), a representative ligand protein with cellular uptake ability, which has been used in the delivery of various cargos. Tf was modified with several biotin molecules through a photocleavable linker, and then the biotinylated Tf (bTf) was conjugated with the biotin-binding protein, streptavidin (SA), to provide steric hindrance to block the interaction with the Tf receptor. Without exposure to light, the cellular uptake of the bTf-SA complex was effectively inhibited. In response to light exposure, the complex was degraded with the release of Tf, leading to cellular uptake of Tf. Similarly, the cellular uptake of Tf-doxorubicin (Dox) conjugates could be suppressed by caging with biotinylation and SA binding, and the intracellular delivery of Dox could be triggered in a light-dependent manner. The intracellularly accumulated Dox decreased the cell viability to 25% because of the cell growth inhibitory effect of Dox. These results provided proof of principle that the caged Tf can be employed as a photoactivatable molecular device for the intracellular delivery of cargos.</description><identifier>ISSN: 1043-1802</identifier><identifier>EISSN: 1520-4812</identifier><identifier>DOI: 10.1021/acs.bioconjchem.1c00159</identifier><identifier>PMID: 34328322</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antibiotics, Antineoplastic - administration & dosage ; Antibiotics, Antineoplastic - chemistry ; Antibiotics, Antineoplastic - pharmacokinetics ; Biotin ; Biotin-binding protein ; Biotinylation ; Cell Line, Tumor ; Cell viability ; Delayed-Action Preparations - administration & dosage ; Delayed-Action Preparations - chemistry ; Delayed-Action Preparations - pharmacokinetics ; Doxorubicin ; Doxorubicin - administration & dosage ; Doxorubicin - chemistry ; Doxorubicin - pharmacokinetics ; Exposure ; Humans ; Intracellular ; Ligands ; Light ; Models, Molecular ; Neoplasms - drug therapy ; Proteins ; Receptors ; Steric hindrance ; Streptavidin ; Transferrin ; Transferrin - administration & dosage ; Transferrin - chemistry ; Transferrin - pharmacokinetics</subject><ispartof>Bioconjugate chemistry, 2021-08, Vol.32 (8), p.1535-1540</ispartof><rights>2021 American Chemical Society</rights><rights>Copyright American Chemical Society Aug 18, 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a451t-abead40f614bf36cfa2b7f978c36b441c896aaa779aea404dee9b54a1d1b29153</citedby><cites>FETCH-LOGICAL-a451t-abead40f614bf36cfa2b7f978c36b441c896aaa779aea404dee9b54a1d1b29153</cites><orcidid>0000-0003-4822-7469 ; 0000-0002-7418-6237</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.1c00159$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.bioconjchem.1c00159$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34328322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaguchi, Satoshi</creatorcontrib><creatorcontrib>Takamori, Satoshi</creatorcontrib><creatorcontrib>Yamamoto, Kazuho</creatorcontrib><creatorcontrib>Ishiwatari, Akira</creatorcontrib><creatorcontrib>Minamihata, Kosuke</creatorcontrib><creatorcontrib>Yamada, Eriko</creatorcontrib><creatorcontrib>Okamoto, Akimitsu</creatorcontrib><creatorcontrib>Nagamune, Teruyuki</creatorcontrib><title>Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery</title><title>Bioconjugate chemistry</title><addtitle>Bioconjugate Chem</addtitle><description>Photoactivatable ligand proteins are potentially useful for light-induced intracellular delivery of therapeutic and diagnostic cargos through receptor-mediated cellular uptake. Here, we report the simple and effective caging of transferrin (Tf), a representative ligand protein with cellular uptake ability, which has been used in the delivery of various cargos. Tf was modified with several biotin molecules through a photocleavable linker, and then the biotinylated Tf (bTf) was conjugated with the biotin-binding protein, streptavidin (SA), to provide steric hindrance to block the interaction with the Tf receptor. Without exposure to light, the cellular uptake of the bTf-SA complex was effectively inhibited. In response to light exposure, the complex was degraded with the release of Tf, leading to cellular uptake of Tf. Similarly, the cellular uptake of Tf-doxorubicin (Dox) conjugates could be suppressed by caging with biotinylation and SA binding, and the intracellular delivery of Dox could be triggered in a light-dependent manner. The intracellularly accumulated Dox decreased the cell viability to 25% because of the cell growth inhibitory effect of Dox. These results provided proof of principle that the caged Tf can be employed as a photoactivatable molecular device for the intracellular delivery of cargos.</description><subject>Antibiotics, Antineoplastic - administration & dosage</subject><subject>Antibiotics, Antineoplastic - chemistry</subject><subject>Antibiotics, Antineoplastic - pharmacokinetics</subject><subject>Biotin</subject><subject>Biotin-binding protein</subject><subject>Biotinylation</subject><subject>Cell Line, Tumor</subject><subject>Cell viability</subject><subject>Delayed-Action Preparations - administration & dosage</subject><subject>Delayed-Action Preparations - chemistry</subject><subject>Delayed-Action Preparations - pharmacokinetics</subject><subject>Doxorubicin</subject><subject>Doxorubicin - administration & dosage</subject><subject>Doxorubicin - chemistry</subject><subject>Doxorubicin - pharmacokinetics</subject><subject>Exposure</subject><subject>Humans</subject><subject>Intracellular</subject><subject>Ligands</subject><subject>Light</subject><subject>Models, Molecular</subject><subject>Neoplasms - drug therapy</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Steric hindrance</subject><subject>Streptavidin</subject><subject>Transferrin</subject><subject>Transferrin - administration & dosage</subject><subject>Transferrin - chemistry</subject><subject>Transferrin - pharmacokinetics</subject><issn>1043-1802</issn><issn>1520-4812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EgvL4BYjEhk2Kx3ZeSyivSkggKOto7NolxY2LnVTK35OqBSE2rGYW594ZHULOgA6BMrhEFYaycsrVc_WuF0NQlEJS7JABJIzGIge22-9U8Bhyyg7IYQhzSmkBOdsnB1xwlnPGBuTltdG-UmhtF1239qOLRjir6lnkTDTxWAejva_qyDgfPb-7xqFqqhU2KK2OxnXjUWlrW4s-utG2WmnfHZM9gzbok-08Im93t5PRQ_z4dD8eXT3GKBJoYpQap4KaFIQ0PFUGmcxMkeWKp1IIUHmRImKWFahRUDHVupCJQJiCZAUk_IhcbHqX3n22OjTlogrrb7DWrg0lS5KMMZ6nokfP_6Bz1_q6_66nMgCeQsp6KttQyrsQvDbl0lcL9F0JtFxrL3vt5S_t5VZ7nzzd9rdyoac_uW_PPcA3wLrh5_Z_tV-wuJUl</recordid><startdate>20210818</startdate><enddate>20210818</enddate><creator>Yamaguchi, Satoshi</creator><creator>Takamori, Satoshi</creator><creator>Yamamoto, Kazuho</creator><creator>Ishiwatari, Akira</creator><creator>Minamihata, Kosuke</creator><creator>Yamada, Eriko</creator><creator>Okamoto, Akimitsu</creator><creator>Nagamune, Teruyuki</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4822-7469</orcidid><orcidid>https://orcid.org/0000-0002-7418-6237</orcidid></search><sort><creationdate>20210818</creationdate><title>Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery</title><author>Yamaguchi, Satoshi ; Takamori, Satoshi ; Yamamoto, Kazuho ; Ishiwatari, Akira ; Minamihata, Kosuke ; Yamada, Eriko ; Okamoto, Akimitsu ; Nagamune, Teruyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a451t-abead40f614bf36cfa2b7f978c36b441c896aaa779aea404dee9b54a1d1b29153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics, Antineoplastic - administration & dosage</topic><topic>Antibiotics, Antineoplastic - chemistry</topic><topic>Antibiotics, Antineoplastic - pharmacokinetics</topic><topic>Biotin</topic><topic>Biotin-binding protein</topic><topic>Biotinylation</topic><topic>Cell Line, Tumor</topic><topic>Cell viability</topic><topic>Delayed-Action Preparations - administration & dosage</topic><topic>Delayed-Action Preparations - chemistry</topic><topic>Delayed-Action Preparations - pharmacokinetics</topic><topic>Doxorubicin</topic><topic>Doxorubicin - administration & dosage</topic><topic>Doxorubicin - chemistry</topic><topic>Doxorubicin - pharmacokinetics</topic><topic>Exposure</topic><topic>Humans</topic><topic>Intracellular</topic><topic>Ligands</topic><topic>Light</topic><topic>Models, Molecular</topic><topic>Neoplasms - drug therapy</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Steric hindrance</topic><topic>Streptavidin</topic><topic>Transferrin</topic><topic>Transferrin - administration & dosage</topic><topic>Transferrin - chemistry</topic><topic>Transferrin - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, Satoshi</creatorcontrib><creatorcontrib>Takamori, Satoshi</creatorcontrib><creatorcontrib>Yamamoto, Kazuho</creatorcontrib><creatorcontrib>Ishiwatari, Akira</creatorcontrib><creatorcontrib>Minamihata, Kosuke</creatorcontrib><creatorcontrib>Yamada, Eriko</creatorcontrib><creatorcontrib>Okamoto, Akimitsu</creatorcontrib><creatorcontrib>Nagamune, Teruyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioconjugate chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, Satoshi</au><au>Takamori, Satoshi</au><au>Yamamoto, Kazuho</au><au>Ishiwatari, Akira</au><au>Minamihata, Kosuke</au><au>Yamada, Eriko</au><au>Okamoto, Akimitsu</au><au>Nagamune, Teruyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery</atitle><jtitle>Bioconjugate chemistry</jtitle><addtitle>Bioconjugate Chem</addtitle><date>2021-08-18</date><risdate>2021</risdate><volume>32</volume><issue>8</issue><spage>1535</spage><epage>1540</epage><pages>1535-1540</pages><issn>1043-1802</issn><eissn>1520-4812</eissn><abstract>Photoactivatable ligand proteins are potentially useful for light-induced intracellular delivery of therapeutic and diagnostic cargos through receptor-mediated cellular uptake. Here, we report the simple and effective caging of transferrin (Tf), a representative ligand protein with cellular uptake ability, which has been used in the delivery of various cargos. Tf was modified with several biotin molecules through a photocleavable linker, and then the biotinylated Tf (bTf) was conjugated with the biotin-binding protein, streptavidin (SA), to provide steric hindrance to block the interaction with the Tf receptor. Without exposure to light, the cellular uptake of the bTf-SA complex was effectively inhibited. In response to light exposure, the complex was degraded with the release of Tf, leading to cellular uptake of Tf. Similarly, the cellular uptake of Tf-doxorubicin (Dox) conjugates could be suppressed by caging with biotinylation and SA binding, and the intracellular delivery of Dox could be triggered in a light-dependent manner. The intracellularly accumulated Dox decreased the cell viability to 25% because of the cell growth inhibitory effect of Dox. These results provided proof of principle that the caged Tf can be employed as a photoactivatable molecular device for the intracellular delivery of cargos.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>34328322</pmid><doi>10.1021/acs.bioconjchem.1c00159</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4822-7469</orcidid><orcidid>https://orcid.org/0000-0002-7418-6237</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-1802 |
ispartof | Bioconjugate chemistry, 2021-08, Vol.32 (8), p.1535-1540 |
issn | 1043-1802 1520-4812 |
language | eng |
recordid | cdi_proquest_miscellaneous_2557223864 |
source | MEDLINE; American Chemical Society Journals |
subjects | Antibiotics, Antineoplastic - administration & dosage Antibiotics, Antineoplastic - chemistry Antibiotics, Antineoplastic - pharmacokinetics Biotin Biotin-binding protein Biotinylation Cell Line, Tumor Cell viability Delayed-Action Preparations - administration & dosage Delayed-Action Preparations - chemistry Delayed-Action Preparations - pharmacokinetics Doxorubicin Doxorubicin - administration & dosage Doxorubicin - chemistry Doxorubicin - pharmacokinetics Exposure Humans Intracellular Ligands Light Models, Molecular Neoplasms - drug therapy Proteins Receptors Steric hindrance Streptavidin Transferrin Transferrin - administration & dosage Transferrin - chemistry Transferrin - pharmacokinetics |
title | Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T01%3A06%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sterically%20Bulky%20Caging%20of%20Transferrin%20for%20Photoactivatable%20Intracellular%20Delivery&rft.jtitle=Bioconjugate%20chemistry&rft.au=Yamaguchi,%20Satoshi&rft.date=2021-08-18&rft.volume=32&rft.issue=8&rft.spage=1535&rft.epage=1540&rft.pages=1535-1540&rft.issn=1043-1802&rft.eissn=1520-4812&rft_id=info:doi/10.1021/acs.bioconjchem.1c00159&rft_dat=%3Cproquest_cross%3E2557223864%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2571136162&rft_id=info:pmid/34328322&rfr_iscdi=true |